SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-17-310473
Filing Date
2017-10-16
Accepted
2017-10-16 09:30:32
Documents
12
Period of Report
2017-11-30
Effectiveness Date
2017-10-16

Document Format Files

Seq Description Document Type Size
1 DEF 14A d470120ddef14a.htm DEF 14A 379038
2 GRAPHIC g470120001.jpg GRAPHIC 42419
3 GRAPHIC g470120002.jpg GRAPHIC 45203
4 GRAPHIC g470120003.jpg GRAPHIC 7303
5 GRAPHIC g470120004.jpg GRAPHIC 16246
6 GRAPHIC g470120005.jpg GRAPHIC 33045
7 GRAPHIC g470120dsp2a.jpg GRAPHIC 5423
8 GRAPHIC g470120g1010064728005.jpg GRAPHIC 2068
9 GRAPHIC g470120g1010064728129.jpg GRAPHIC 677
10 GRAPHIC g470120g1010064728207.jpg GRAPHIC 782
11 GRAPHIC g470120g1010064728894.jpg GRAPHIC 734
12 GRAPHIC g470120g63u25.jpg GRAPHIC 4874
  Complete submission text file 0001193125-17-310473.txt   600496
Mailing Address 3611 VALLEY CENTER DRIVE SUITE 500 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTER DRIVE SUITE 500 SAN DIEGO CA 92130 858-792-6300
MEI Pharma, Inc. (Filer) CIK: 0001262104 (see all company filings)

IRS No.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEF 14A | Act: 34 | File No.: 000-50484 | Film No.: 171137787
SIC: 2834 Pharmaceutical Preparations